Quero-Hernández A, Sánchez-Navarro LM, Socorro-López Z, Carrasco-Daza D

Language: Spanish
References: 22
Page: 50-56
PDF size: 329.98 Kb.

ABSTRACT

REFERENCES

1. Wilson L, Barry M, Edelson R, Heald P. Lymphoma of theskin. En: Devita V, Hellman S, Rosenberg S, editores. Cancer. Principles and practice of oncology. 5a ed.USA: Lippincott Williams and Wilkins; 1997. p.2220-33.

2. Harris NL,Jaffe ES, Stein H.A revised European-American classification of lymphoid neoplasm’s: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-92.

3. Carbia S, Hochman A, Deicas I. Linfomas cutáneos ulcera-dos, diez años de experiencia. Medicina. 2000;60:565-9.

4. Connors JM, His ED, Foss FM. Lymphoma of the skin. Hematology. 2002;263-82.

5. Lever WF, Schaumburg LG. Histopathology of the skin. Philadelphia: JB Lippincott; 1990. p.819.

6. Yunis J, Mayer M, Amesen M. bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N Engl J Med. 1989;320:1047.

7. Wnag CY, Snow JL. Lymphoma associated with human immunodeficiency virus infection. Mayo Clin Proceed. 1995;70:665.

8. Oono T, Arata J, Masuda T, Ohtsuki Y. Coexistence of Hidroa vacciniforme and malignant lymphoma. Arch Dermatol. 1986;122:1306-9..

9. Ibarra-Durán G, Rodríguez-Jurado R, Rodríguez-Moguel L. Linfoma T cutáneo angiocéntrico en una niña con hidroa vacciniforme. Rev Mex Dermatol. 1991;5:344-8.

10. Ruiz-Maldonado R, Millán-Parrilla F, Orozco-Covarrubias M.Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol. 1995;32:37-44.

11. Iwatsuki K, Ohtsuka M, Harada H. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol. 1997;133:1081-6.

12. Cho KH, Kim CW, Heo DS. Epstein-Barr virus-associated peripheral T cell lymphoma in adults with hydroa vacciniforme-like lesions. Clin Exp Dermatol. 2001;26:242-7.

13. Tabata N, Aiba S, Ichinohazama R. Hydroa vacciniforme-like lymphomatoid papulosis in a Japanes child: a new subset. J Am Dermatol. 1995;32:378-81.

14. Barrionuevo C, Anderson B, Zevallos-Giampetri E. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. App Immunohistochem Mol Morphol. 2002;10:7-14.

15. Heo EP, Park SH, Kim TH. Artificial reproduction of atypical hydroa vacciniforme caused by latent Epstein-Barrvirus infection. International J Dermatol. 2003;42:476-9.

16. Willemze R, Kerl W, Sterry E. EORTC Classification for primary cutaneous lymphoma: a proposal from the cutaneous study group of the European Organization for Research and Treatment of Cancer. Blood. 1997;1:354-71.

17. Fink-PR, Zenahlik P, Back B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Heath Organization) based on clinicopathology features observed in a large group of patients. Blood. 2002;99:800-5.

18. Lipford E, Margolich J, Fauci A. Angiocentric immunoproliferative lesions: a clinico pathology spectrum of postthymic T cell proliferations. Blood. 1985;5:1674.

19. Skarin A, Dorfman D. Non Hodkgin’s lymphoma: current classification and management. Cancer JC. 1997;47:351-72.

20. Hoppe-R. The role of radiation therapy in the management of the non-Hodgkin’s lymphomas. Cancer (Abstracts). 1985;

21. Glick J, Kim K, Earle J. An ECOG randomized phase IIItrial of CHOP vs CHOP+ radiotherapy for intermediate grade early stage non-Hodgkin’s lymphoma. Proc Am Soc Clin Oncol (Abstracts). 1995.

22. Magaña M, Sanguenza P, Gil-Beristain J, Sánchez-Sosa S. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma. J Am Acad Dermatol. 1998;38:574-9.